Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Abstract 5180: CXCR7 mediates an immune-suppressive tumor microenvironment and promotes prostate cancer progression

Hongshun Shi, Ziqi Zhang, Lourdes Brea, Zhuoyuan Lin, Viriya Keo, Sambhavi Senthil, BaoHan Thi Vo, Galina Gritsina, Xiaojun Kong, Jonathan Zhao, Haydn Thomas Kissick, Xiuwei Zhang, Jindan Yu

Cancer Res (2025) 85 (8_Supplement_1): 5180.

https://doi.org/10.1158/1538-7445.AM2025-5180

Published: 21 April 2025

View articletitled, Abstract 5180: CXCR7 mediates an immune-suppressive tumor microenvironment and promotes prostate cancer progression

Journal Articles

Abstract 7215: Targeting EZH2 in castration-resistance prostate cancer using a novel PROTAC

Qi Chu, Wanqing Xie, Galina Gritsina, Xiaodong Lu, Ka Wing Fong, Zhiquan Lei, Hongshun Shi, Lourdes Brea, Jonathan Zhao, Gary Schiltz, Jindan Yu

Cancer Res (2025) 85 (8_Supplement_1): 7215.

https://doi.org/10.1158/1538-7445.AM2025-7215

Published: 21 April 2025

View articletitled, Abstract 7215: Targeting EZH2 in castration-resistance prostate cancer using a novel PROTAC

Journal Articles

Abstract 7418: LongFuse: Detecting gene fusion transcripts from high throughput long-read single cell RNA sequencing data

Cheng-Kai Shiau, Yueying He, Hsiao-Yun Lin, Lina Lu, Xiao-Dong Lu, Jindan Yu, Ruli Gao

Cancer Res (2024) 84 (6_Supplement): 7418.

https://doi.org/10.1158/1538-7445.AM2024-7418

Published: 22 March 2024

View articletitled, Abstract 7418: LongFuse: Detecting gene fusion transcripts from high throughput long-read single cell RNA sequencing data

Journal Articles

Abstract IA002: Genomic and epigenomic regulation during prostate cancer progression

Jindan Yu

Cancer Res (2023) 83 (11_Supplement): IA002.

https://doi.org/10.1158/1538-7445.PRCA2023-IA002

Published: 02 June 2023

View articletitled, Abstract IA002: Genomic and epigenomic regulation during prostate cancer progression

Journal Articles

Abstract 4756: NSD1/2 histone methyltransferases regulate cell growth in HPV-negative head and neck squamous cell carcinoma (HNSCC)

Iuliia Topchu, Igor Bychkov, Petr Makhov, Evgeny Izumchenko, John Karanicolas, Jindan Yu, Jochen Lorch, Yanis Boumber

Cancer Res (2023) 83 (7_Supplement): 4756.

https://doi.org/10.1158/1538-7445.AM2023-4756

Published: 04 April 2023

View articletitled, Abstract 4756: NSD1/2 histone methyltransferases regulate cell growth in HPV-negative head and neck squamous cell carcinoma (HNSCC)

Journal Articles

Abstract 3718: NSD histone methyltransferases drive cell proliferation in HPV-negative head and neck squamous cell carcinoma (HNSCC)

Iuliia Topchu, Rajendra Pangeni, Igor Bychkov, Petr Makhov, John Karanicolas, Jindan Yu, Erica Golemis, Jochen Lorch, Yanis Boumber

Cancer Res (2022) 82 (12_Supplement): 3718.

https://doi.org/10.1158/1538-7445.AM2022-3718

Published: 15 June 2022

View articletitled, Abstract 3718: NSD histone methyltransferases drive cell proliferation in HPV-negative head and neck squamous cell carcinoma (HNSCC)

Journal Articles

Abstract LB032: CXCR7 drives prostate cancer growth through AURKA activation

Galina Gritsina, Zhuoyuan Lin, Ka Wing Fong, Xiaodong Lu, Changsheng Zhao, Jindan Yu

Cancer Res (2022) 82 (12_Supplement): LB032.

https://doi.org/10.1158/1538-7445.AM2022-LB032

Published: 15 June 2022

View articletitled, Abstract LB032: CXCR7 drives prostate cancer growth through AURKA activation

Journal Articles

Abstract LB082: Genome-wide CRISPR activation screen identifies PRRX2 as an enzalutamide resistance gene in prostate cancer

Yara R. Rodriguez, Kenji Unno, Mihai Truica, Zachary R. Chalmers, Young A Yoo, Rajita Vatapalli, Vinay Sagar, Jindan Yu, Barbara Lysy, Huiying Han, Sarki A. Abdulkadir

Cancer Res (2022) 82 (12_Supplement): LB082.

https://doi.org/10.1158/1538-7445.AM2022-LB082

Published: 15 June 2022

View articletitled, Abstract LB082: Genome-wide CRISPR activation screen identifies PRRX2 as an enzalutamide resistance gene in prostate cancer

Journal Articles

A Genome-Wide CRISPR Activation Screen Identifies PRRX2 as a Regulator of Enzalutamide Resistance in Prostate Cancer

Yara Rodríguez, Kenji Unno, Mihai I. Truica, Zachary R. Chalmers, Young A. Yoo, Rajita Vatapalli, Vinay Sagar, Jindan Yu, Barbara Lysy, Maha Hussain, Huiying Han, Sarki A. Abdulkadir

Cancer Res (2022) 82 (11): 2110–2123.

https://doi.org/10.1158/0008-5472.CAN-21-3565

Published: 06 June 2022

View articletitled, A Genome-Wide CRISPR Activation Screen Identifies PRRX2 as a Regulator of Enzalutamide Resistance in Prostate Cancer

Includes: Supplementary data

Journal Articles

Correction: Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer

Shangze Li, Ka-wing Fong, Galina Gritsina, Ali Zhang, Jonathan C. Zhao, Jung Kim, Adam Sharp, Wei Yuan, Caterina Aversa, Ximing J. Yang, Peter S. Nelson, Felix Y. Feng, Arul M. Chinnaiyan, Johann S. de Bono, Colm Morrissey, Matthew B. Rettig, Jindan Yu

Cancer Res (2020) 80 (10): 2072.

https://doi.org/10.1158/0008-5472.CAN-20-0768

Published: 15 May 2020

View articletitled, Correction: Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer

Journal Articles

Abstract 2099: N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer

Adeline Berger, Nicholas Brady, Rohan Bareja, Brian Robinson, Vincenza Conteduca, Michael Augello, Loredana Puca, Adnan Ahmed, Xiaodong Lu, Inah Hwang, Alyssa Bagadion, Andrea Sboner, Olivier Elemento, Jihye Paik, Jindan Yu, Christopher Barbieri, Noah Dephoure, Himisha Beltran, David S. Rickman

Cancer Res (2019) 79 (13_Supplement): 2099.

https://doi.org/10.1158/1538-7445.AM2019-2099

Published: 01 July 2019

View articletitled, Abstract 2099: N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer

Journal Articles

Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer

Cancer Res (2019) 79 (10): 2580–2592.

https://doi.org/10.1158/0008-5472.CAN-18-2812

Published: 15 May 2019

View articletitled, Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer

Includes: Supplementary data

Journal Articles

Abstract 4886: Ligand-independent CXCR7 activation of MAPK signaling leads to prostate cancer enzalutamide resistance

Shangze Li, Ka-Wing Fong, Galina Gritsina, Ali Zhang, Jonathan C. Zhao, Jung Kim, Jindan Yu

Cancer Res (2018) 78 (13_Supplement): 4886.

https://doi.org/10.1158/1538-7445.AM2018-4886

Published: 01 July 2018

View articletitled, Abstract 4886: Ligand-independent CXCR7 activation of MAPK signaling leads to prostate cancer enzalutamide resistance

Journal Articles

Abstract 1497: A PRC2 independent role of EZH2 in androgen receptor signaling in prostate cancer

Yongik Lee, Jung a Kim, Zhao Changsheng, Xiadong Lu, Ka Wing Fong, Jindan Yu

Cancer Res (2018) 78 (13_Supplement): 1497.

https://doi.org/10.1158/1538-7445.AM2018-1497

Published: 01 July 2018

View articletitled, Abstract 1497: A PRC2 independent role of EZH2 in androgen receptor signaling in prostate cancer

Journal Articles

Abstract LB-207: A novel role for polycomb group protein BMI1 in prostate cancer

Sen Zhu, Dongyu Zhang, Lin Yan, Weihua Jiang, Qipeng Liu, Rui Wang, Bo Xia, Jonathan C. Zhao, Rong-Fu Wang, Xiaobing Shi, Hung-ming Lam, Xuesen Dong, Jindan Yu, Kaifu Chen, Qi Cao

Cancer Res (2018) 78 (13_Supplement): LB-207.

https://doi.org/10.1158/1538-7445.AM2018-LB-207

Published: 01 July 2018

View articletitled, Abstract LB-207: A novel role for polycomb group protein BMI1 in prostate cancer

Journal Articles

Abstract 1521: Role of Trim28 in prostate cancer

Ka-Wing Fong, Jonathan Zhao, Bin Zheng, Jindan Yu

Cancer Res (2018) 78 (13_Supplement): 1521.

https://doi.org/10.1158/1538-7445.AM2018-1521

Published: 01 July 2018

View articletitled, Abstract 1521: Role of Trim28 in prostate cancer

Journal Articles

PADI2-Mediated Citrullination Promotes Prostate Cancer Progression

Lin Wang, Guanhua Song, Xiang Zhang, Tingting Feng, Jihong Pan, Weiwen Chen, Muyi Yang, Xinnuo Bai, Yu Pang, Jindan Yu, Jinxiang Han, Bo Han

Cancer Res (2017) 77 (21): 5755–5768.

https://doi.org/10.1158/0008-5472.CAN-17-0150

Published: 31 October 2017

View articletitled, PADI2-Mediated Citrullination Promotes Prostate Cancer Progression

Includes: Supplementary data

Journal Articles

Abstract 2080: Polycomb-mediated disruption of an AR-feedback loop drives castration-resistant prostate cancer

Ka-Wing Fong, Jonathan Zhao, Jung Kim, Shangze Li, Angela Yang, Bing Song, Laure Rittié, Ming Hu, Ximing Yang, Bernard Perbal, Jindan Yu

Cancer Res (2017) 77 (13_Supplement): 2080.

https://doi.org/10.1158/1538-7445.AM2017-2080

Published: 01 July 2017

View articletitled, Abstract 2080: Polycomb-mediated disruption of an AR-feedback loop drives castration-resistant prostate cancer

Journal Articles

Polycomb-Mediated Disruption of an Androgen Receptor Feedback Loop Drives Castration-Resistant Prostate Cancer

Ka-wing Fong, Jonathan C. Zhao, Jung Kim, Shangze Li, Yeqing A. Yang, Bing Song, Laure Rittie, Ming Hu, Ximing Yang, Bernard Perbal, Jindan Yu

Cancer Res (2017) 77 (2): 412–422.

https://doi.org/10.1158/0008-5472.CAN-16-1949

Published: 16 January 2017

View articletitled, Polycomb-Mediated Disruption of an Androgen Receptor Feedback Loop Drives Castration-Resistant Prostate Cancer

Includes: Supplementary data

Journal Articles

Abstract 1801: FOXA1, a novel regulator of neuroendocrine differentiation

Jung Kim, Hongjian Jin, Jonathan Zhao, Vamsi Parimi, Ximing Yang, Jindan Yu

Cancer Res (2016) 76 (14_Supplement): 1801.

https://doi.org/10.1158/1538-7445.AM2016-1801

Published: 15 July 2016

View articletitled, Abstract 1801: FOXA1, a novel regulator of neuroendocrine differentiation

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 5180: CXCR7 mediates an immune-suppressive tumor microenvironment and promotes prostate cancer progression

Abstract 7215: Targeting EZH2 in castration-resistance prostate cancer using a novel PROTAC

Abstract 7418: LongFuse: Detecting gene fusion transcripts from high throughput long-read single cell RNA sequencing data

Abstract IA002: Genomic and epigenomic regulation during prostate cancer progression

Abstract 4756: NSD1/2 histone methyltransferases regulate cell growth in HPV-negative head and neck squamous cell carcinoma (HNSCC)

Abstract 3718: NSD histone methyltransferases drive cell proliferation in HPV-negative head and neck squamous cell carcinoma (HNSCC)

Abstract LB032: CXCR7 drives prostate cancer growth through AURKA activation

Abstract LB082: Genome-wide CRISPR activation screen identifies PRRX2 as an enzalutamide resistance gene in prostate cancer

A Genome-Wide CRISPR Activation Screen Identifies PRRX2 as a Regulator of Enzalutamide Resistance in Prostate Cancer

Correction: Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer

Abstract 2099: N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer

Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer

Abstract 4886: Ligand-independent CXCR7 activation of MAPK signaling leads to prostate cancer enzalutamide resistance

Abstract 1497: A PRC2 independent role of EZH2 in androgen receptor signaling in prostate cancer

Abstract LB-207: A novel role for polycomb group protein BMI1 in prostate cancer

Abstract 1521: Role of Trim28 in prostate cancer

PADI2-Mediated Citrullination Promotes Prostate Cancer Progression

Abstract 2080: Polycomb-mediated disruption of an AR-feedback loop drives castration-resistant prostate cancer

Polycomb-Mediated Disruption of an Androgen Receptor Feedback Loop Drives Castration-Resistant Prostate Cancer

Abstract 1801: FOXA1, a novel regulator of neuroendocrine differentiation

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only